Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
16:00 EDT 4 Jul 2012 | Nature Publishing
Drug resistance presents a challenge to the treatment of cancer patients. Many studies have focused on cell-autonomous mechanisms of drug resistance. By contrast, we proposed that the tumour micro-environment confers innate resistance to therapy. Her..
Original Article: Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
More From BioPortfolio on "Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
